The rise in spending among Medicare beneficiaries: The role of chronic disease prevalence and changes in treatment intensity
The rise in spending among Medicare beneficiaries: The role of chronic disease prevalence and changes in treatment intensity
复制标题
DOI：
10.1377/hlthaff.25.w378
复制
发表时间：
2006-09-01
期刊：
影响因子：
9.7
通讯作者：
Howard, David H.
中科院分区：
文献类型：
--
作者：
Thorpe, Kenneth E.;Howard, David H.
我们研究了治疗疾病患病率上升对医疗保险受益人医疗保健支出增长的影响。几乎所有的支出增长都与五种或五种以上疾病的医疗管理有关。这可以追溯到真实疾病患病率的上升和临床治疗阈值的变化。以代谢综合征为例，我们发现，在不到十年的时间里，接受药物治疗的患者比例增加了11.5个百分点。这就提出了一个重要的问题，即医疗保险如何为复杂的医疗管理服务支付费用。
We examine the impact of the rise in treated disease prevalence on the growth in Medicare beneficiaries' health care spending. Virtually all of this spending growth is associated with patients who are under medical management for five or more conditions. This is traced to both a rise in true disease prevalence and changes in clinical treatment thresholds. Using the metabolic syndrome as a case study, we find that the share of patients treated with medications has increased 11.5 percentage points in less than ten years. This raises important questions about the "fit" of how Medicare pays for services for complex medical management.